Ultrapure IBMX

IBMX is a competitive phosphodiesterase inhibitor. This product is provided as 55.55 mg of dry powder.

Catalog #: 92-0007 Size: 55.55 mg


Biological Information
Background Information:
IBMX, also referred to as 3-isobutyl-1-methylxanthine, is a competitive phosphodiesterase inhibitor which raises cAMP levels, activates PKA, inhibits TNF-alpha, synthesizes leukotrienes, and reduces a number of inflammation and innate immune mechanisms. IBMX also is known among the class of compounds to act as a nonselective adenosine receptor antagonist.
Target Name:
Ultrapure IBMX
Product Type:
Control Ligands & Inhibitors
Drug Discovery & Development
Storage Conditions:
Store at ≤-20°C. Please avoid multiple freeze/thaw cycles.
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Additional Information


92-0007 Datasheet

View Document